Victoria Cerino

UNMC student enrollment reaches record high

Student enrollment at UNMC reached an all-time high for the second straight year, as 3,067 students are enrolled this fall, a 2.2 percent increase over last year’s total of 3,002.

Sep 8, 2006

UNMC offers treatment option for some MS patients

Jane Fallon is hoping for a cure – or even a partial one – for her multiple sclerosis (MS). Fallon’s disease has relapsed so she was happy to learn that Tysabri, a drug once taken off the market, is available again. Physicians say a vast majority of patients with MS may benefit.

Aug 30, 2006

Burger King raises $200,000 for cancer research

Burger King customers, employees and staff provided hope to pediatric cancer patients, raising an unprecedented $200,000 for pediatric cancer research through its third annual “BK Beat Cancer for Kids” campaign. All proceeds benefit the UNMC Eppley Cancer Center.

Aug 29, 2006

UNMC helps provide free books to underserved children

Officials from Reach Out and Read, the Literacy Center for the Midlands, students and staff from the Omaha Primrose School of Legacy, as well as employees of UNMC and The Nebraska Medical Center, recently were on hand to celebrate a donation of $100,000 to the national Reach Out and Read program.

Aug 24, 2006

Murray man battles staphylococcus infection

John Morgan knows the seriousness of staphylococcus aureus. He nearly died from it. While at the medical center, he participated in an international study that ultimately demonstrated the effectiveness and safety of a new drug – daptomycin.

Aug 22, 2006

Researcher studies tropical parasitic disease

Developing new and better antimalarial medications has been fruitful for Jonathan Vennerstrom, Ph.D., and his research team. Some of the compounds the team developed to treat malaria appear to be effective in killing a parasite that causes schistosomiasis.

Aug 21, 2006

Antibiotic study shows promise in treating infections

UNMC researchers are part of an international team whose study results offer the medical world another drug – daptomycin — to treat the growing threat of methicillin-resistant staphylococcus aureus (MRSA). The article appears in the Aug. 17 issue of the New England Journal of Medicine.

Aug 17, 2006